| Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients A Vijenthira, IY Gong, TA Fox, S Booth, G Cook, B Fattizzo, F Martín-Moro, ... Blood, The Journal of the American Society of Hematology 136 (25), 2881-2892, 2020 | 622 | 2020 |
| Survival study of hospitalised patients with concurrent COVID‐19 and haematological malignancies F Martín‐Moro, J Marquet, M Piris, BM Michael, AJ Sáez, M Corona, ... British journal of haematology 190 (1), e16, 2020 | 188 | 2020 |
| Bone marrow infiltration by flow cytometry at diffuse large B‐cell lymphoma NOS diagnosis implies worse prognosis without considering bone marrow histology F Martín‐Moro, M Piris‐Villaespesa, J Marquet‐Palomanes, ... Cytometry Part B: Clinical Cytometry 98 (6), 525-528, 2020 | 12 | 2020 |
| Early cellular and humoral responses developed in oncohematological patients after vaccination with one dose against COVID-19 S Rodríguez-Mora, M Corona, M Torres, G Casado-Fernández, ... Journal of Clinical Medicine 11 (10), 2803, 2022 | 7 | 2022 |
| Early detection of lysosomal diseases by screening of cases of idiopathic splenomegaly and/or thrombocytopenia with a next‐generation sequencing gene panel G Muñoz, D García‐Seisdedos, C Ciubotariu, M Piris‐Villaespesa, ... JIMD reports 51 (1), 53-61, 2020 | 6 | 2020 |
| TRBC1 expression assessed by flow cytometry as a novel marker of clonality in cutaneous αβ T‐cell lymphomas with peripheral blood involvement F Martin‐Moro, I Martin‐Rubio, JA Garcia‐Vela British Journal of Dermatology 187 (4), 623-625, 2022 | 3 | 2022 |
| Diffuse follicular lymphoma variant with a typical diagnostic pattern and an unusually aggressive clinical presentation F Martín-Moro, J Marquet-Palomanes, M Piris-Villaespesa, ... International Journal of Hematology 112, 136-138, 2020 | 3 | 2020 |
| Patients with secondary acute myeloid leukemia undergoing allogeneic stem‐cell transplant have inferior outcomes than de novo acute myeloid leukemia regardless minimal residual … C Núñez‐Torrón Stock, C Jiménez Chillón, F Martín Moro, ... Hematological Oncology 41 (4), 753-761, 2023 | 2 | 2023 |
| Acute leukemia of ambiguous lineage, not otherwise specified with FLT3‐ITD mutation and a possible origin in the common lymphoid progenitor F Martin‐Moro, JA Garcia‐Vela Cytometry Part B: Clinical Cytometry 104 (5), 400-403, 2023 | 2 | 2023 |
| The impact of lockdown during the COVID-19 pandemic on newly acute myeloid leukemia patients: single-centre comparative study between 2019 and 2020 cohorts in Madrid F Martín-Moro, C Núnez-Torrón, L Pérez-Lamas, C Jiménez-Chillón, ... Leukemia research 101, 106518, 2021 | 2 | 2021 |
| Intracranial hemorrhage as presentation of chronic lymphocytic leukemia successfully treated with ibrutinib F Martín-Moro, M García-Cosío, J Marquet-Palomanes, M López-Gutiérrez, ... Annals of Hematology, 1-3, 2021 | 2 | 2021 |
| Correlation of morphological and flow cytometric findings in the diagnosis of transient red cell aplasia due to parvovirus B19 infection MF Berta Mercedes, MR Isaac, LP Claudia, MM Fernando, GA Luis, ... Cytometry Part B: Clinical Cytometry 100 (3), 296-298, 2021 | 1 | 2021 |
| Myelomatous pleural effusion with plasmablastic morphology and high genetic complexity as isolated extramedullary relapse F Martín-Moro, A Roncancio, A Benito, M Talavera, J Villarrubia, ... Annals of Hematology 99, 2705-2706, 2020 | 1 | 2020 |
| Comparative Review of the Current and Future Strategies to Evaluate Bone Marrow Infiltration at Diffuse Large B-Cell Lymphoma Diagnosis F Martin-Moro, J Lopez-Jimenez, JA Garcia-Marco, JA Garcia-Vela Diagnostics 14 (6), 658, 2024 | | 2024 |
| Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia CNT Stock, CJ Chillón, FM Moro, JM Palomanes, MP Villaespesa, ... Frontiers in Oncology 14, 2024 | | 2024 |
| Autologous Stem Cell Transplantation Remains a Curative Option As Second Line Treatment for Patients with Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geth-TC … L Bento, A Gutiérrez, C Martínez, C Ortí, M Sorribes, AC Caballero, ... Blood 142, 786, 2023 | | 2023 |
| CHANGES IN NATURAL KILLER IMMUNE RECONSTITUTION FOLLOWING POST-TRANSPLANT CYCLOPHOSPHAMIDE A Luna de Abia, G Moreno JImenez, F Martin-Moro, C Jimenez-Chillon, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 474-475, 2023 | | 2023 |
| INCIDENCE AND PREDICTIVE FACTORS OF PLATINUM‐ASSOCIATED NEPHROTOXICITY IN PATIENTS WITH LYMPHOID MALIGNANCIES; A 15‐YEAR EXPERIENCE OUTSIDE CLINICAL TRIALS. J Marquet, F Martin‐Moro, A Gomis, A Lario, MT Tenorio, P Herrera, ... Hematological Oncology 41, 2023 | | 2023 |
| IMMUNOPHENOTYPIC CHARACTERIZATION OF RICHTER SYNDROME DIFFUSE LARGE B‐CELL LYMPHOMA TYPE AND COMPARISON WITH THE ORIGINAL CHRONIC LYMPHOCYTIC LEUKEMIA. F Martin‐Moro, J Marquet‐Palomanes, M Piris‐Villaespesa, ... Hematological Oncology 41, 2023 | | 2023 |
| Induction (MATRix) Followed by Transplantation in Primary Central Nervous System Lymphoma. Experience of the GELTAMO (Grupo Español de Linfoma y Trasplante de Medula Ósea). P Lopez‐Pereira, S Romero‐Dominguez, F Martin‐Moro, ... Hematological Oncology 41, 2023 | | 2023 |
